Thirteen homes changed hands last year in the ZIP code Anthropic just leased into. All thirteen were in two buildings. Both buildings opened in 1989.
That is 02142, Kendall Square, the densest concentration of lab and office square footage in the country, and over the twelve months ending August 31 it produced thirteen closed residential sales out of 719 across Cambridge. Not one of them was built in this century. Zero closings of anything built since 2023. I pulled those numbers myself out of MLS PIN because no public tracker slices that small, and they are the cleanest answer I have found to the question buyers keep asking me.
The question is some version of this: Cambridge lab vacancy is at a record, developers are giving space back, so is the glut finally going to loosen up housing near Kendall Square? It is a reasonable thing to assume. Every office-to-residential conversion story this year has trained people to read an empty commercial building as a housing unit in waiting. And on September 9, Anthropic signed a 24,000 square foot lease at One Kendall Square and showed why the assumption is only half right.
Thirteen Sales, Two Buildings, Both Finished in 1989
Start with what the Kendall Square housing market actually is, because most people arguing about it have never looked. Here is every residential closing recorded in 02142 between September 1, 2025 and August 31, 2026. Not a top ten. All of them.
| Address | Built | Price | $/sf | Days | % of ask |
| 75-83 Cambridge Pkwy E902 | 1989 | $2,980,000 | $1,560 | 207 | 81.6% |
| 75-83 Cambridge Pkwy W702 | 1989 | $2,900,000 | $1,499 | 231 | 89.9% |
| 75-83 Cambridge Pkwy 303 | 1989 | $2,350,000 | $1,774 | 329 | 87.7% |
| 75-83 Cambridge Pkwy E1202 | 1989 | $2,200,000 | $1,397 | 132 | 88.2% |
| 75-83 Cambridge Pkwy W1003 | 1989 | $2,140,000 | $1,342 | 74 | 93.9% |
| 75-83 Cambridge Pkwy 203 | 1989 | $1,995,000 | $1,500 | 64 | 100.0% |
| 75-83 Cambridge Pkwy E807 | 1989 | $1,790,000 | $1,105 | 225 | 94.2% |
| 10 Rogers St PH19 | 1989 | $997,500 | $683 | 25 | 99.8% |
| 10 Rogers St 606 | 1989 | $991,000 | $776 | 106 | 99.6% |
| 10 Rogers St 308 | 1989 | $850,000 | $735 | 148 | 77.3% |
| 10 Rogers St 415 | 1989 | $809,000 | $753 | 35 | 101.3% |
| 10 Rogers St 213 | 1989 | $790,000 | $809 | 93 | 90.3% |
| 10 Rogers St 703 | 1989 | $730,000 | $846 | 73 | 93.7% |
| 13 sales, 2 addresses | both 1989 | median $1,790,000 | $1,137 avg | median 106 | 92.1% avg |
Two buildings on the Lechmere Canal, both delivered a year before CambridgeSide opened across the water. The rest of Cambridge closed at 99.3 to 101.5 percent of the original asking price depending on the ZIP. Kendall Square closed at 92.1 percent and sat a median 106 days. That is not a hot market and it is not a cold one. It is barely a market at all, because there is almost nothing there to trade.
So when somebody tells you the lab glut is going to fix housing supply near Kendall, ask them which buildings. The honest answer right now is two, and they were finished when the first Bush was president.
What Anthropic Signed, and What It Did Not Ask For
On September 9 Anthropic announced a lease for 24,000 square feet across two floors at One Kendall Square, the office, lab and retail complex on Binney Street that Alexandria Real Estate Equities bought from DivcoWest in 2016 for $725 million. The company has been running a roughly 50 person local team out of a WeWork in Central Square. The new space holds 120 workstations. Move in is early 2027.
Two details matter more than the square footage. The first is that Anthropic told the Boston Globe it is not seeking any state or local tax break for the expansion. In a state where nearly every corporate headcount announcement comes bundled with an incentive package, a company more than doubling its local footprint and declining to ask is a signal about how badly it wants the address.
The second is the landlord’s own occupancy. Banker & Tradesman reported the Alexandria campus at One Kendall Square finished the second quarter 86 percent occupied. Hold that against a Greater Boston lab market that CBRE put at 28.7 percent vacant in Q2 2026, up 250 basis points year over year from 26.2 percent. The record everyone quotes, 28.0 percent, was set in Q4 2025 and has already been broken twice since. Meanwhile the trophy Kendall campus is running at 14 percent vacancy. Same city. Same quarter. Half the emptiness.
The Vacancy Rate Is an Average of Two Markets
This is the part that gets lost. A metro vacancy rate is a weighted average, and Cambridge’s lab inventory splits into three submarkets that behave nothing alike. Lincoln Property Company’s Q2 2026 lab report breaks them out.
Look at the leasing column rather than the vacancy column. East Cambridge did 947,110 square feet of leasing in a single quarter. West Cambridge did 10,402. That is a ninety to one ratio between submarkets whose inventories differ by six to one. Sanofi alone accounted for most of the East Cambridge number with a ten year, 900,000 square foot extension at 350 and 450 Water Street, which is itself the point: when a large tenant recommits in Greater Boston right now, it recommits in Kendall.
Two more things worth understanding before you read another vacancy headline. Vacancy counts space nobody occupies. Availability counts space you could lease, including space a tenant is still paying for and trying to hand off. Mid Cambridge is 15.5 percent vacant and 36.3 percent available, and the gap is almost entirely sublease inventory. That distinction is why the same market can look like a disaster or a soft patch depending on which number an article picked.
Takeda Is Not Giving Back Kendall Square
The biggest give back in the market is the one people cite most loosely. In February, Takeda put roughly 630,000 square feet on the Cambridge sublease market across 35 Lansdowne Street, 40 Lansdowne Street and 300 Massachusetts Avenue, plus about 125,000 square feet at 75-125 Binney Street, as Bisnow reported. Headlines called it a retreat.
It is a consolidation. Takeda signed a fifteen year lease in 2022 on 585 Third Street, a roughly 650,000 square foot BioMed Realty development in Kendall Square that delivers in the second half of this year, and it is pulling its scattered legacy space into that one campus. The company’s Cambridge footprint goes from about 1.56 million square feet across seven buildings to roughly 1.43 million across four. The net reduction is on the order of 130,000 square feet. The gross number that made the headlines is more than four times that.
And notice the addresses. Lansdowne Street and 300 Mass Ave are Mid Cambridge. The space Takeda is keeping is Kendall. This is the entire pattern in one tenant: legacy, off-core, older buildings go back to the market, and the best located square footage gets held or re-signed. AstraZeneca is doing a version of the same thing at 290 Binney Street, a 570,000 square foot anchored delivery landing this half. Neither of those buildings is ever going to be an apartment.
AI Leasing Is Already Bigger Than Cambridge’s Vacant Lab
Anthropic’s 24,000 square feet is small on its own. It is not small as a data point, because it lands inside a trend CBRE has been measuring for a while. In its 2026 Tech Gateway Office Markets report, CBRE totals cumulative AI company leasing from 2019 through the first quarter of this year by market.
Francisco
Valley
Boston is fourth at 3.7 million square feet, behind only the two Bay Area markets and Manhattan. Tech’s share of all United States office leasing hit 22.7 percent in the first quarter of 2026, up from 15.3 percent a year earlier and from a cyclical low of 12.7 percent in 2023. Nationally that is a story about office. In Cambridge it is a story about lab, because in Kendall Square the two are the same buildings with different mechanical systems.
The local roster is filling in. AI Proteins took 40,000 square feet at Related Beal’s One Kenmore Square in January for its headquarters. Lovable took 6,000 downtown at One Lincoln. LabCentral turned vacant space at 700 Main Street into an AI BioHub for artificial intelligence focused biotech startups instead of waiting for a traditional lab tenant. In February the Healey administration announced a state partnership with OpenAI alongside the launch of the Massachusetts AI Coalition. None of those are conversions to housing. All of them are square footage coming off the table.
Nine Days in September
I do not usually get to make an argument with a calendar. This month I can.
One of those three things required a signature. The other two required a moratorium, a working group, a rezoning, a Planning Board, and a City Council that is still amending the rules nineteen months after passing them. That asymmetry is the whole argument, and it did not need a theory to demonstrate it. It happened in nine days.
The Housing Is Going Three Miles Away
Cambridge is building. It is just not building where the lab market is tightest.
Every meaningful lab to housing pivot in this city has landed in West Cambridge, the 39.5 percent vacancy submarket out by Alewife and Fresh Pond. Boylston Properties swapped lab plans at 745 Concord Avenue for a residential tower. Toll Brothers and PGIM opened The Laurent at 55 Wheeler Street in June 2024, 525 units a ten minute walk from Alewife station. And on September 17 the Planning Board approved Healthpeak’s Cambridge Point, 4.6 million square feet on 46 acres in the Alewife Quadrangle with more than 2,300 homes, a project that began when Healthpeak spent $625 million assembling land, got frozen by the city’s 2022 moratorium on Alewife lab and office development, waited out a rezoning the Council finalized in September 2023, and only now has an approval.
One Kendall Square to Alewife station is about 3.3 miles as the crow flies. In Cambridge terms that is a different city. It is also the correct outcome, which is the part I want to be fair about. The Quadrangle has large parcels, surface parking, a subway terminus and a zoning framework that now requires housing alongside large commercial development. Andrew Copelotti of Boylston Properties put it plainly to Banker & Tradesman in 2024: “Thank God the moratorium came along. We’d have a built or half-built life science building in a tough market.” He is right. That space should be housing.
But read the Cambridge Point approval conditions and you find the sequencing problem in black and white. The pedestrian bridge connecting the project to Alewife station is required to start construction when 50 percent of the commercial portion is complete. The housing’s transit connection is gated on the lab and office space getting built first.
Housing Is the Only Bidder That Has to Ask Permission
Here is the mechanism, stated as plainly as I can.
When a well located lab or office building empties out, two kinds of capital look at it. One is a tenant with a signed term sheet who can be in the building in six months and who is bidding a rent number. The other is a residential developer whose bid is contingent on a zoning change, a permit, a financing, a construction cycle and, in Cambridge, a Planning Board. The first bidder closes in weeks. The second closes in years, if at all.
Landlords are not choosing housing over lab or lab over housing on ideology. They are choosing certainty. And because a discounted trophy rent still underwrites better than a residential redevelopment pro forma with five years of entitlement risk in front of it, the well located square footage clears to the faster bidder every time. Cambridge asking rents have fallen hard, from roughly $113 per square foot triple net at the Q3 2021 peak to $85.34 in Q2 2026, about 24 percent. A 24 percent haircut on Kendall rent is still a number a housing developer cannot outbid.
That leaves conversion to the buildings nobody is bidding on. Obsolete floor plates. Bad transit. Wrong block. Those are genuine candidates, and Boston has been working that problem with its own downtown conversion program, which I wrote about when the lab glut mostly got skipped by the conversion pipeline. The uncomfortable part is that the buildings that clear the conversion test are usually the ones you would least want to live near a job in.
The Conversion Math, Honestly
Let me put real numbers on the hope, because the hope is not crazy, it is just smaller than people think.
And that top line assumes conversion is even physically possible, which for purpose built lab it usually is not, and assumes the 2.6 million vacant square feet outside West Cambridge would be available, which the leasing data says it will not be.
Set that against what the city has actually produced. Cambridge legalized multifamily housing citywide on February 10, 2025, ending single family zoning and allowing four stories by right with a two story bonus for inclusionary units on larger lots. It was a genuine landmark. In the twelve months that followed, the city permitted fifty smaller developments and zero large scale projects, up from 43 buildings in 2024. Vice Mayor Burhan Azeem’s assessment was blunt: “we’ve not actually seen any of these buildings actually open yet.” Then on September 16 two Council committees voted to add setbacks and open space requirements back on top.
What the Sales Data Says About Buying in Cambridge Right Now
None of the above has loosened anything, and the closing record shows it. Here is what Cambridge did over the last twelve months, by ZIP, straight out of MLS PIN.
| ZIP | Area | Sales | Avg price | $/sf | % of ask | Built 2023+ |
| 02138 | Harvard Sq., North Cambridge | 262 | $1,978,877 | $965 | 99.3% | 9 |
| 02139 | Central Sq., Cambridgeport | 222 | $1,427,741 | $933 | 100.9% | 11 |
| 02140 | Porter Sq., Alewife | 122 | $1,639,780 | $879 | 101.5% | 9 |
| 02141 | East Cambridge | 100 | $1,226,015 | $860 | 97.5% | 5 |
| 02142 | Kendall Square | 13 | $1,655,577 | $1,137 | 92.1% | 0 |
Kendall Square carries the highest price per square foot in the city, $1,137, and 1.8 percent of the sales. Cambridge’s newest housing, the 34 closings of homes built since 2023, averaged $2,580,117. Whatever the lab market is doing, it is not putting downward pressure on any of that. There are 209 active listings in Cambridge as I write this, averaging $1.9 million, with 62 more pending.
What I Would Actually Do With This
If you are buying in Cambridge, stop underwriting a future supply wave that is not coming to your block. The vacancy headline is real and it is describing buildings you will never live in. Price the neighborhood you want on its own closing record, and in East Cambridge that record says 100 sales a year at $860 a foot and 97.5 percent of ask, which is a normal, competitive market with no glut discount in it.
If you are investing, the split is the opportunity. West Cambridge is where the basis is cheapest, the rezoning is done, the entitlement risk is now proven survivable, and the Cambridge Point approval just established what 46 acres of the Quadrangle is worth. That is a ten year story with real execution risk and it is the only part of Cambridge where the lab glut converts into housing at scale. East Cambridge is a different trade entirely. You are buying scarcity next to an employment base that is currently being rebuilt by tenants with more capital than the biotechs they are replacing.
If you own near Kendall already, the Anthropic lease is good news and it is not the kind of good news that shows up next quarter. A 120 workstation office does not move a housing market. A hundred of them would, and the direction of travel is the thing to watch, not the size of any one signature.
What I would watch next: whether any AI tenant takes a full building in Kendall rather than two floors, whether Takeda’s Lansdowne Street space finds a subtenant or sits, and what the full City Council does on September 28 with the setback amendments. If Cambridge tightens its own housing ordinance in the same month it approves 2.6 million square feet of new commercial space at Alewife, that tells you which bidder this city is actually set up to serve.
We track Cambridge closings by ZIP and by submarket every month, including the cuts in this article, because the published town-level numbers are too coarse to price a specific block. If you are weighing a purchase near Kendall, Central or Alewife and want the real closing record for that pocket rather than a citywide average, reach out and I will pull it for you. If you already own in Cambridge and want to know what the last twelve months did to your number, start with a home value estimate.
Sources
- Boston Globe, Anthropic signs lease for 24,000 square foot office near Kendall Square, September 9, 2026
- Bisnow, Anthropic Doubling Local Presence With Cambridge Office Lease
- Banker & Tradesman, Anthropic Inks 24K SF Kendall Square Lease, September 10, 2026
- CBRE, Boston Metro Life Science Figures Q2 2026
- Lincoln Property Company, Q2 2026 Lab Market Report, Boston, Cambridge, Suburbs
- CBRE, 2026 Tech Gateway Office Markets
- Bisnow, Takeda Looks To Put 630K SF Up For Sublease Across Three Cambridge Properties, February 13, 2026
- Banker & Tradesman, Cambridge Approves 4.6M SF Healthpeak Alewife Project, September 17, 2026
- Harvard Crimson, Cambridge Sees Early-Stage Developments One Year After Overhauling Its Zoning Code, March 26, 2026
- Cambridge Day, Zoning update may see major changes, September 16, 2026
- City of Cambridge CDD, Cambridge Zones for Multifamily Housing Citywide, February 2025
- Cambridge Day, Close to a quarter of Cambridge lab space sits vacant, October 22, 2025
- Banker & Tradesman, Will Lab Slump Translate into Housing Gains?, September 29, 2024
- New England Real Estate Journal, Related Beal completes 40,000 s/f lease to AI Proteins at One Kenmore Sq.
- MLS PIN closed sales, Cambridge MA, 719 transactions September 1, 2025 through August 31, 2026, compiled by BMN Boston

